In the wake of the Democrats sweep of Congress, Leerink Partners analyst David Risinger highlighted potential implications ...
Ask a biopharma commercial team where to launch first and, until recently, the answer was mostly about opportunity. Most ...
Oncology company BeOne Medicines said the US Food and Drug Administration has accepted and granted Priority Review to its ...
With the COINS Act around the corner, Chinese biotech companies are feeling the pressure of heightened regulatory scrutiny ...
Japanese drugmaker Nxera Pharma today announced that its has entered into an exclusive global license agreement with US ...
Swiss biotech Idorsia announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation ...
US biotech major Amgen reported third-quarter 2026 revenues of $10.37 billion, up 8% year-on-year and ahead of analyst ...
Danish pharma major Novo’s shares were up 3.4% at 279.15 kroner this morning, after it released third quarter 2026 financial ...
US pharma major AbbVie has expanded its UK research and development facility in Oxford as part of more than £120 million ...
Few medicines have left as clear a mark on drug regulation as thalidomide. Its use as a sedative in the late 1950s and early ...
French pharma company Servier said its recently acquired muscular dystrophy candidate sevasemten failed to meet the primary ...
In January 1923, Frederick Banting, Charles Best and James Collip transferred their patent rights for making insulin to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results